Search Results for keywords:"analytical purposes"

Found 4 results

Search Results: keywords:"analytical purposes"

💰 Only
Oldest Newest
  • 2025-01766 — Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc.
    Type:Notice
    Citation:90 FR 8303
    Reading Time:about a minute or two

    Aveva Drug Delivery Systems, Inc. has applied to the Drug Enforcement Administration, a part of the Justice Department, to register as an importer of certain controlled substances. They intend to import these substances solely for analytical purposes and not for commercial sale. Interested parties can submit their comments or objections electronically, or request a hearing, by February 27, 2025. The registration is subject to specific regulations and permits as outlined in federal laws.

    Simple Explanation

    Aveva Drug Delivery Systems, Inc. wants to bring some special medicines to the U.S. so they can study them, and people have until February 27, 2025, to say what they think about it or ask for a meeting.

  • 2025-02599 — Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
    Type:Notice
    Citation:90 FR 9556
    Reading Time:about a minute or two

    Janssen Pharmaceuticals Inc. has filed an application with the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances for analytical purposes. Public comments or objections regarding this application are accepted until March 17, 2025. Hearings can also be requested by this date. Comments should be submitted via the Federal eRulemaking Portal, and requests for hearings must be sent to the DEA at specified addresses.

    Simple Explanation

    Janssen Pharmaceuticals wants permission from the government to bring in certain special medicines to study them, and people have until March 17, 2025, to share their thoughts or ask for a meeting about it.

  • 2025-04043 — Importer of Controlled Substances Application: Meridian Medical Technologies, LLC
    Type:Notice
    Citation:90 FR 11996
    Reading Time:about a minute or two

    Meridian Medical Technologies, LLC has applied to the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances. The company plans to import these substances solely for analytical purposes and has no authorization for other activities involving these drugs. The DEA is accepting public comments or objections to this application until April 14, 2025, and has outlined procedures for submitting these electronically via regulations.gov. Requests for a hearing regarding the application must also be submitted by the same date to designated DEA offices in Springfield, Virginia.

    Simple Explanation

    Meridian Medical Technologies, LLC wants to bring in some special medicines from other countries just to study them, and people have until mid-April 2025 to say if they think it's a good or bad idea.

  • 2021-03919 — Importer of Controlled Substances Application: Myonex Inc
    Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    Myonex Inc has applied for registration as an importer of specific controlled substances, according to a notice from the Drug Enforcement Administration (DEA). The substances are intended for use in clinical trials, research, and analytical purposes, and not for commercial sale of finished dosage forms. Interested parties have until March 29, 2021, to submit written comments or objections, or to request a hearing regarding this application. Written submissions should be directed to the DEA at their office in Springfield, Virginia.

    Simple Explanation

    Myonex Inc wants to bring in some special medicines from other countries to use in experiments and tests but not to sell them in stores. If anyone has questions or concerns, they can tell the people in charge by March 29, 2021.